{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:21:02Z","timestamp":1790745662433,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00210-024-03763-8","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T05:30:40Z","timestamp":1736573440000},"page":"8419-8430","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sexual dysfunctions associated with antipsychotic drug intake: a retrospective analysis of the FDA adverse events reporting system (FAERS)"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8373-0727","authenticated-orcid":false,"given":"Johanna","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamin","family":"Jeridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichit","family":"Buspavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"3763_CR1","unstructured":"Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A (1995) Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 137-141"},{"key":"3763_CR2","doi-asserted-by":"crossref","unstructured":"Baldwin D, Mayers A (2003) Sexual side-effects of antidepressant and antipsychotic drugs 9:202-210. http:\/\/apt.rcpsych.org\/","DOI":"10.1192\/apt.9.3.202"},{"key":"3763_CR3","doi-asserted-by":"crossref","unstructured":"Begley CM, Higgins A (2006) Iatrogenic sexual dysfunction and withholding of information iatrogenic sexual dysfunction and the protective withholding of information: in whose best interest? J Psychiatr Mental Health Nurs 13:437\u2013446","DOI":"10.1111\/j.1365-2850.2006.01001.x"},{"key":"3763_CR4","doi-asserted-by":"publisher","unstructured":"Bobes J, Garc\u00eda-Portilla MP, Rejas J, Hern\u00e1ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A (2003) Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29:125\u2013147. https:\/\/doi.org\/10.1080\/713847170","DOI":"10.1080\/713847170"},{"key":"3763_CR5","doi-asserted-by":"publisher","unstructured":"Boer MKD, Castelein S, Wiersma D, Schoevers RA, Knegtering H (2015) The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull 41:674\u2013686. https:\/\/doi.org\/10.1093\/schbul\/sbv001","DOI":"10.1093\/schbul\/sbv001"},{"key":"3763_CR6","doi-asserted-by":"publisher","unstructured":"Boora K, Chiappone K, Dubovsky S, Xu J (2010) Ziprasidone-induced spontaneous orgasm. J Psychopharmacol 24:947\u2013948. https:\/\/doi.org\/10.1177\/0269881108100321","DOI":"10.1177\/0269881108100321"},{"key":"3763_CR7","doi-asserted-by":"crossref","unstructured":"Bostwick JR, Guthrie SK, Ellingrod VL (2009) Antipsychotic-induced hyperprolactinemia (vol\u00a029)","DOI":"10.1592\/phco.29.1.64"},{"key":"3763_CR8","doi-asserted-by":"publisher","unstructured":"Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS (2004) Prolactinemia is uncoupled from central D2\/D3 dopamine receptor occupancy in amisulpride treated patients. Psychopharmacol 175:367\u2013373. https:\/\/doi.org\/10.1007\/s00213-004-1826-6","DOI":"10.1007\/s00213-004-1826-6"},{"key":"3763_CR9","doi-asserted-by":"publisher","unstructured":"Cheng Y, Chen Y, Zhao X, Mou F, Wang W, Yu Qian R, S, (2024) The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/fphar.2024.1423075","DOI":"10.3389\/fphar.2024.1423075"},{"key":"3763_CR10","doi-asserted-by":"publisher","unstructured":"Dervaux A, Omari FE (2005) Sexual dysfunction in schizophrenics patients, the role of antipsychotics. Press Med 34:529\u2013532. https:\/\/doi.org\/10.1016\/s0755-4982(05)83966-1","DOI":"10.1016\/s0755-4982(05)83966-1"},{"key":"3763_CR11","unstructured":"Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde eV (2019)S3-leitlinie schizophrenie 91(46). https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/038-009.html"},{"key":"3763_CR12","doi-asserted-by":"publisher","unstructured":"Fleischhacker WW, Uchida H (2014) Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int J Neuropsychopharmacol 17:1083\u20131093. https:\/\/doi.org\/10.1017\/S1461145712000399","DOI":"10.1017\/S1461145712000399"},{"key":"3763_CR13","doi-asserted-by":"publisher","unstructured":"Fujii A, Yasui-Furukori N, Sugawara N, Sato Y, Nakagami T, Saito M, Kaneko S (2010) Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuro-Psychopharmacol Biol Psychiatry 34:288\u2013293. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.11.022","DOI":"10.1016\/j.pnpbp.2009.11.022"},{"key":"3763_CR14","doi-asserted-by":"publisher","unstructured":"Fujioi J, Iwamoto K, Banno M, Kikuchi T, Aleksic B, Ozaki N (2017) Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. Pharmacopsychiatry 50:74\u201378. https:\/\/doi.org\/10.1055\/s-0042-116323","DOI":"10.1055\/s-0042-116323"},{"key":"3763_CR15","doi-asserted-by":"publisher","unstructured":"Haddad PM, Wieck A (2004) Antipsychotic-induced hyperprolactinaemia mechanisms, clinical features and management. Drugs 64:2291\u20132314. https:\/\/doi.org\/10.2165\/00003495-200464200-00003","DOI":"10.2165\/00003495-200464200-00003"},{"key":"3763_CR16","doi-asserted-by":"publisher","unstructured":"Hashimoto N et al (2023) Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project. BMC Psychiatry 23. https:\/\/doi.org\/10.1186\/s12888-023-04908-4","DOI":"10.1186\/s12888-023-04908-4"},{"key":"3763_CR17","doi-asserted-by":"publisher","unstructured":"Hwang T, Shah T, Sadeghi-Nejad H (2021) A review of antipsychotics and priapism. Sex Med Rev 9:464\u2013471. https:\/\/doi.org\/10.1016\/j.sxmr.2020.10.003","DOI":"10.1016\/j.sxmr.2020.10.003"},{"key":"3763_CR18","doi-asserted-by":"publisher","unstructured":"Just MJ (2015) The influence of atypical antipsychotic drugs on sexual function. Neuropsychiatr Dis Treat 11:1655\u20131661. https:\/\/doi.org\/10.2147\/NDT.S84528","DOI":"10.2147\/NDT.S84528"},{"key":"3763_CR19","doi-asserted-by":"publisher","unstructured":"Kennedy SH, Rizvi S (2009) Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 29:157\u2013164. https:\/\/doi.org\/10.1097\/JCP.0b013e31819c76e9","DOI":"10.1097\/JCP.0b013e31819c76e9"},{"key":"3763_CR20","doi-asserted-by":"publisher","unstructured":"Kikuchi T, Uchida H, Suzuki T, Watanabe K, Kashima H (2011) Patients\u2019 attitudes toward side effects of antidepressants: an internet survey. Eur Arch Psychiatry Clin Neurosci 261:103\u2013109. https:\/\/doi.org\/10.1007\/s00406-010-0124-z","DOI":"10.1007\/s00406-010-0124-z"},{"key":"3763_CR21","doi-asserted-by":"publisher","unstructured":"Knegtering H, van den Bosch R, Castelein S, Bruggeman R, Sytema S, van Os J (2008) Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology 33:711\u2013717. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.02.008","DOI":"10.1016\/j.psyneuen.2008.02.008"},{"key":"3763_CR22","doi-asserted-by":"publisher","unstructured":"Kr\u00fcger TH, Hartmann U, Schedlowski M (2005) Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 23:130\u2013138. https:\/\/doi.org\/10.1007\/s00345-004-0496-7","DOI":"10.1007\/s00345-004-0496-7"},{"key":"3763_CR23","doi-asserted-by":"crossref","unstructured":"Lohse MJ, Seifert J, Bleich S (2021) Psychopharmaka.In Ludwig WD, M\u00fchlbauer B, Seifert R (eds) Arzneiverordnungs-report 2021, pp 689\u2013725. Berlin, Heidelberg: Springer Berlin Heidelberg. https:\/\/doi.org\/10.1007\/978-3-662-63825-5_39","DOI":"10.1007\/978-3-662-63825-5_39"},{"key":"3763_CR24","unstructured":"Maguire GA (2002) Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J clin psychiatry 63:56\u201362"},{"key":"3763_CR25","doi-asserted-by":"publisher","unstructured":"Mahmoud A, Hayhurst KP, Drake RJ, Lewis SW (2011) Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial. Schizophr Res Treat 2011:1\u20136. https:\/\/doi.org\/10.1155\/2011\/596898","DOI":"10.1155\/2011\/596898"},{"key":"3763_CR26","doi-asserted-by":"publisher","unstructured":"Melis MR, Sanna F, Argiolas A (2022) Dopamine, erectile function and male sexual behavior from the past to the present: a review. Brain Scie 12. https:\/\/doi.org\/10.3390\/brainsci12070826","DOI":"10.3390\/brainsci12070826"},{"key":"3763_CR27","doi-asserted-by":"publisher","unstructured":"M\u00f6ller HJ (2005) Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? Eur Arch Psychiatry Clin Neurosci 255:190\u2013201. https:\/\/doi.org\/10.1007\/s00406-005-0587-5","DOI":"10.1007\/s00406-005-0587-5"},{"key":"3763_CR28","doi-asserted-by":"crossref","unstructured":"Peuskens J, Sienaert P, Hert MD (1998) Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry 13:23\u201330","DOI":"10.1016\/S0924-9338(98)82005-1"},{"key":"3763_CR29","doi-asserted-by":"publisher","unstructured":"P\u00f6ttgen J, Rose A, Vis WVD, Engelbrecht J, Pirard M, Lau S, Cerqueda C (2018) Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: a scoping review. PLoS ONE 13. https:\/\/doi.org\/10.1371\/journal.pone.0193381","DOI":"10.1371\/journal.pone.0193381"},{"key":"3763_CR30","doi-asserted-by":"publisher","unstructured":"Puijenbroek EPV, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC (2002) A comparison of measures of disproportionality for signal detection is spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11:3\u201310. https:\/\/doi.org\/10.1002\/pds.668","DOI":"10.1002\/pds.668"},{"key":"3763_CR31","doi-asserted-by":"publisher","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10:796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","DOI":"10.7150\/ijms.6048"},{"key":"3763_CR32","doi-asserted-by":"publisher","unstructured":"Salata B, Kluczna A, Dzier\u017canowski T (2022) Opioid-induced sexual dysfunction in cancer patients. Cancers 14. https:\/\/doi.org\/10.3390\/cancers14164046","DOI":"10.3390\/cancers14164046"},{"key":"3763_CR33","doi-asserted-by":"publisher","unstructured":"Serretti A, Chiesa A (2011) A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Neuropsychopharmacol 26:130\u2013140. https:\/\/doi.org\/10.1097\/YIC.0b013e328341e434","DOI":"10.1097\/YIC.0b013e328341e434"},{"key":"3763_CR34","doi-asserted-by":"publisher","unstructured":"Silva C, Rebelo M, Chendo I (2023) Managing antipsychotic-related sexual dysfunction in patients with schizophrenia. Expert Rev Neurother 23(12):1147\u20131155. https:\/\/doi.org\/10.1080\/14737175.2023.2281399","DOI":"10.1080\/14737175.2023.2281399"},{"key":"3763_CR35","doi-asserted-by":"publisher","unstructured":"Souaiby L, Kazour F, Zoghbi M, Khalil RB, Richa S (2020) Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication. J Mental Health 29:623\u2013630. https:\/\/doi.org\/10.1080\/09638237.2019.1581333","DOI":"10.1080\/09638237.2019.1581333"},{"key":"3763_CR36","doi-asserted-by":"publisher","unstructured":"Su CC, Lai ECC, Yang YHK, Man KK, Kubota K, Setoguchi Stang P, S, (2020) Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: a cross-nation comparison with common data model. J Psychiatric Res 131:77\u201384. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.08.025","DOI":"10.1016\/j.jpsychires.2020.08.025"},{"key":"3763_CR37","doi-asserted-by":"publisher","unstructured":"Tharoor H, Kaliappan A, Gopal S (2015) Sexual dysfunctions in schizophrenia: professionals and patients perspectives. Indian J Psychiatry 57:85\u201387. https:\/\/doi.org\/10.4103\/0019-5545.148532","DOI":"10.4103\/0019-5545.148532"},{"key":"3763_CR38","doi-asserted-by":"publisher","unstructured":"Torre AL, Conca A, Duffy D, Giupponi G, Pompili M, Gr\u00f6zinger M (2013) Sexual dysfunction related to psychotropic drugs: a critical review part II: Antipsychotics. Pharmacopsychiatry 46:201\u2013208. https:\/\/doi.org\/10.1055\/s-0033-1347177","DOI":"10.1055\/s-0033-1347177"},{"key":"3763_CR39","doi-asserted-by":"crossref","unstructured":"Traish A, Kim NN, Moreland RB, Goldstein I (2000) Role of alpha adrenergic receptors in erectile function. Int J Impot Res 12:48-63. www.nature.com\/ijir","DOI":"10.1038\/sj.ijir.3900506"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03763-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03763-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:52:00Z","timestamp":1752555120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03763-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3763"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03763-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the FAERS database is accessible to the public and patient records are anonymized and de-identified, ethical clearance and informed consent are not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}